Xtl Biopharmaceuticals (XTLB) Net Income Growth (5y) (2014 - 2024)
Xtl Biopharmaceuticals (XTLB) Net Income Growth (5y) (2014 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,583.17 Bn | 67,582.89 Bn | - |
| 2 | Nanobiotix | 1,947.22 Bn | 1,947.15 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 473.21 Bn | 468.42 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.29 Bn | 116.04 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.29 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - |
| 8 | Argenx Se | 56.63 Bn | 51.45 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.79 Bn | 37.79 Bn | - |
| 10 | Xtl Biopharmaceuticals | 2.51 Bn | 2.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 2.53% |
| Sep 30, 2024 | 15.50% |
| Jun 30, 2024 | -28.62% |
| Mar 31, 2024 | 34.72% |
| Dec 31, 2023 | 7.23% |
| Sep 30, 2023 | -0.45% |
| Jun 30, 2023 | -66.27% |
| Mar 31, 2023 | -24.99% |
| Dec 31, 2022 | -135.93% |
| Sep 30, 2022 | -6.92% |
| Jun 30, 2022 | 27.14% |
| Mar 31, 2022 | 20.28% |
| Dec 31, 2021 | -8.07% |
| Sep 30, 2021 | 45.30% |
| Jun 30, 2021 | 8.68% |
| Mar 31, 2021 | 16.66% |
| Dec 31, 2020 | 22.80% |
| Sep 30, 2020 | 13.30% |
| Jun 30, 2020 | 12.66% |
| Mar 31, 2020 | -15.09% |